| SKU | ISG000900 |
| Brand | Divakote |
| Categories | Medication & Treatments |
| Color | black |
| Concentrations | 500 Mg |
| Shop by Concerns | Epilepsy |
| Gender | Neutral |
| Shop By Goals | Mobility Support |
| Imported Or Local | Local |
| Ingredient | Divalproex sodium |
| UPC | 6224000396190 |
| Product Form | Tablets |
| Specialty | Clinically Tested Extended Release Prescription only |
| Sub Categories | Anti-Epileptic |
| Warning | Hepatotoxicity risk May cause drowsiness Not for use in case of severe medical conditions Pancreatitis Risk Use with Caution in Pregnancy |
Divakote Er 500 Mg Tablets
Description:
Divakote Er 500 mg tablets are an extended-release prescription anti-epileptic medicine containing divalproex sodium. They are used for the treatment and management of seizure disorders, acute manic episodes associated with bipolar disorder (mania), and for the prophylactic (preventive) treatment of migraine headaches. The extended-release (er) formulation is designed to release the active ingredient gradually over time, helping to maintain more stable blood levels with once-daily dosing, improving seizure control and mood stabilization while potentially reducing peak-related side effects. This product is intended for use under the supervision of a healthcare professional.
Indications:
- Treatment and management of various seizure disorders (epilepsy), including absence seizures, tonic-clonic (grand mal) seizures, complex partial seizures, and seizures associated with Lennox-Gastaut syndrome.
- Management of acute manic episodes associated with bipolar disorder (mania), helping to stabilize mood and reduce symptoms such as elevated mood, irritability, and hyperactivity.
- Prophylactic (preventive) treatment of migraine headaches in adults, reducing the frequency and severity of migraine attacks.
- May be used as monotherapy or as adjunctive therapy with other anti-epileptic drugs, as directed by a neurologist or psychiatrist.
Active Ingredients / Key Components:
- Divalproex sodium – 500 mg per extended-release tablet.
- Equivalent valproate content: exact valproic acid equivalence per tablet is not specified in the available product information.
- Excipients (inactive ingredients) such as tablet core and coating materials are present but not specified in the available data.
Dosage & Administration / How to Use:
- Divakote Er 500 mg is for oral use only and should be swallowed whole with a sufficient amount of water.
- Do not crush, chew, or split the extended-release tablets, as this will affect the controlled-release properties and may increase side effects.
- Recommended dosing is individualized by the physician based on the condition being treated, patient age, body weight, clinical response, and blood valproate levels.
- For epilepsy: therapy is usually started at a low dose and gradually increased to achieve optimal seizure control. Your doctor will determine the starting dose and titration schedule.
- For bipolar mania: dosing is adjusted according to clinical response and tolerability, often starting with a moderate dose and titrating as needed.
- For migraine prophylaxis: treatment is typically started at a low dose and increased as necessary to achieve effective migraine prevention.
- Divakote Er is commonly taken once daily; however, your doctor may adjust frequency depending on your needs.
- Can be taken with or after food to help reduce gastrointestinal side effects. Try to take it at the same time each day.
- If a dose is missed, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed dose.
- Do not stop taking Divakote Er suddenly without medical advice, especially if you are being treated for epilepsy, as this may increase the risk of seizures.
Clinical Benefits:
- Provides effective control of a wide range of seizure types, including absence, tonic-clonic, complex partial, and Lennox-Gastaut–associated seizures.
- Helps stabilize mood and reduce symptoms of acute manic episodes in bipolar disorder, supporting better emotional balance and daily functioning.
- Reduces the frequency and intensity of migraine attacks when used regularly as a preventive treatment.
- Extended-release formulation offers more stable blood levels over 24 hours, which may improve tolerability and adherence compared with immediate-release forms.
Warnings & Contraindications:
- Divakote Er (divalproex sodium) can cause serious liver toxicity, especially during the first 6 months of treatment and in young children or patients with pre-existing liver disease. Liver function tests should be performed before starting therapy and periodically thereafter.
- Contraindicated in patients with known liver disease or significant hepatic dysfunction.
- Contraindicated in patients with known urea cycle disorders due to risk of hyperammonemia and encephalopathy.
- May cause pancreatitis, which can be life-threatening. Seek immediate medical attention if you develop severe abdominal pain, nausea, vomiting, or loss of appetite.
- Use in pregnancy is associated with a high risk of birth defects and developmental disorders. Women of childbearing potential should use effective contraception and discuss alternative treatments with their doctor. Do not use in pregnancy unless clearly needed and prescribed by a specialist.
- Use with caution in patients with kidney impairment, metabolic disorders, or a history of mitochondrial disease.
- May cause drowsiness, dizziness, or impaired concentration. Avoid driving or operating machinery until you know how the medicine affects you.
- Concomitant use with other anti-epileptics, CNS depressants, or medicines affecting liver enzymes may require dose adjustments and close monitoring.
- Regular monitoring of liver function tests, complete blood count, and serum valproate levels may be required, as advised by your doctor.
- Consult your doctor before use if pregnant, nursing, taking other medications, or if you have liver disease, kidney disease, metabolic disorders, or psychiatric conditions.
- Keep out of reach of children.
- Not intended to diagnose, treat, cure, or prevent any disease without medical supervision; it is a prescription-only medicine and must be used exactly as directed by a healthcare professional.
Side Effects:
- Common side effects may include nausea, vomiting, stomach pain, indigestion, diarrhea, loss of appetite, tremor, dizziness, drowsiness, headache, weight gain, hair loss (usually temporary), and changes in menstrual cycle.
- Other possible effects include blurred vision, coordination problems, confusion, mood changes, or increased appetite.
- Serious side effects can include liver problems (jaundice, dark urine, persistent nausea, fatigue), pancreatitis (severe abdominal pain, vomiting), severe skin reactions, blood disorders (easy bruising, bleeding, infections), and high ammonia levels (lethargy, vomiting, changes in mental status).
- Seek immediate medical attention if you experience severe abdominal pain, yellowing of the skin or eyes, unusual bleeding or bruising, severe weakness, confusion, difficulty breathing, rash, swelling of the face or tongue, or any signs of allergic reaction.
- Report any new or worsening mood changes, depression, or suicidal thoughts to your doctor immediately.
Storage Instructions:
Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children.
Specifications:
- Form: Extended-release tablets.
- Strength: 500 mg divalproex sodium per tablet.
- Pack size: 20 extended-release tablets per pack (based on available product information).
- Route of administration: Oral.
Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.
